P Raskin, BW Bode, JB Marks, IB Hirsch, RL … - Diabetes Care, 2003 - Am Diabetes Assoc RESULTS—HbA 1c values decreased similarly for both groups from baseline (8.2
± 1.37% for CSII, 8.0 ± 1.08% for MDI) to end of study (7.6 ± 1.22% for CSII,
7.5 ± 1.22% for MDI). The CSII group showed a trend toward lower ... Cited by 32 - Related articles - All 6 versions
J Wainstein, M Metzger, M Boaz, O Minuchin, … - Diabetic Medicine, 2005 - interscience.wiley.com It is also possible that your web browser is not configured or not able to
display style sheets. In this case, although the visual presentation will be
degraded, the site should continue to be functional. We recommend using the ... Cited by 31 - Related articles - BL Direct - All 4 versions
P Valensi, I Moura, M Le Magoarou, J Paries, G … - Diabetes & metabolism, 1997 - cat.inist.fr Le traitement des diabétiques non insulinodépendants(DNID) obèses en mauvais
équilibre glycémique malgré un traitement anti diabétique oral maximal est
difficile. Dans une série de 82 DNID en surpoids, nous avons étudié ... Cited by 40 - Related articles - BL Direct - All 3 versions
E Berthe, B Lireux, C Coffin, B Goulet-Salmon … - Hormone and Metabolic Research, 2007 - 万方数据资源系统 OBJECTIVE: To compare the effectiveness of two intensified insulin regimens, ie,
pump delivery versus multiple daily injections in patients with type 2 diabetes
not optimally controlled with conventional insulin therapy. RESEARCH DESIGN ... Cited by 12 - Related articles - BL Direct - All 5 versions
- ►diacare.com.tw [PDF] MJJ Pouwels, CJ Tack, AR Hermus, JA … - Diabetic Medicine, 2003 - pt.wkhealth.com Methods In a prospective observational study, eight Type 2 DM patients with
severe insulin resistance (insulin dose 1.92 ± 0.66 U/kg per day (mean ± SD)),
in poor metabolic control (HbA1c 12.0 ± 1.7%), were treated with iv ... Cited by 25 - Related articles - BL Direct - All 6 versions
- Free from Publisher WH Herman, LL Ilag, SL Johnson, CL Martin, J … - Diabetes Care, 2005 - Am Diabetes Assoc RESULTS—Forty-eight CSII subjects (91%) and 50 MDI subjects (93%) completed
the study. Mean A1C fell by 1.7 ± 1.0% in the CSII group to 6.6% and by 1.6 ±
1.2% in the MDI group to 6.4%. The difference in A1C between treatment ... Cited by 85 - Related articles - BL Direct - All 5 versions
- ►diabetesjournals.org [PDF] J Wainstein, M Metzger, ID Wexler, J Cohen, I … - Diabetes Care, 2001 - Am Diabetes Assoc A total of 10 severely obese (BMI > 30 kg/m 2 ) type 2 diabetic patients with
severe insulin resistance (insulin dose of > 1 U · kg −1 · day −1 ) were
recruited from a hospital-based practice. Subjects who qualified for the ... Cited by 12 - Related articles - BL Direct - All 4 versions
AM Jennings, KS Lewis, S Murdoch, JF Talbot … - Diabetes Care, 1991 - Am Diabetes Assoc OBJECTIVE: To compare the effects of continuous subcutaneous insulin infusion
(CSII) and conventional insulin therapy (CIT) in patients with poorly controlled
sulfonylurea-treated diabetes mellitus. RESEARCH DESIGN AND METHODS: ... Cited by 58 - Related articles - All 6 versions
[CITATION] Induction of long-term glycemic control in newly diagnosed type 2 diabetic patients by …
D Bruttomesso, A Pianta, D Crazzolara, E … - Diabetic Medicine, 2002 - interscience.wiley.com It is also possible that your web browser is not configured or not able to
display style sheets. In this case, although the visual presentation will be
degraded, the site should continue to be functional. We recommend using the ... Cited by 49 - Related articles - BL Direct - All 5 versions
